Copyright: ©Author(s) 2026.
World J Transplant. Jun 18, 2026; 16(2): 118288
Published online Jun 18, 2026. doi: 10.5500/wjt.v16.i2.118288
Published online Jun 18, 2026. doi: 10.5500/wjt.v16.i2.118288
Figure 3 Comparative vascular and metabolic profiles of major immunosuppressive classes.
mTOR: Mammalian target of rapamycin; VEGF: Vascular endothelial growth factor.
- Citation: Jahangir S, Zohery M, Diaz Lopez C, Hamed JC, Sarfraz S, Ashraf H, Rafiq T, Ali H, Raza M, Dahiya DS, Khalaf M, Ali H. Immunosuppression and vascular remodeling after liver transplantation: Mechanisms, surrogate markers, and modifiable pathways. World J Transplant 2026; 16(2): 118288
- URL: https://www.wjgnet.com/2220-3230/full/v16/i2/118288.htm
- DOI: https://dx.doi.org/10.5500/wjt.v16.i2.118288